Glomerulonephritis crescentic

Feng L, Chen S, Garcia GE, et al. Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication. Kidney Int 1999 56 612-620. 

Segerer S, Regele H, Mack M, et al. The duffy antigen receptor for chemokines is up-regulated during acute renal transplant rejection and crescentic glomerulonephritis. Kidney Int 2000 58 1546-1556. 

Gregorini, G. et al., Association between silica exposure and necrotizing crescentic glomerulonephritis with p-ANCA and anti-MPO antibodies A hospital-based case-control study, Adv. Exp. Med. Biol. 336, 435, 1993. 

Protective effect of a novel and selective inhibitor of inducible nitric oxide synthase on experimental crescentic glomerulonephritis in WKY rats, Nephrol. Dial. Transplant. 17 (2002), p. 2117-2121... 

Kawaguchi H, Ito K. Antineutrophil cytoplasmic anti-body-positive crescentic glomerulonephritis associated with propylthiouracil therapy. Acta Paediatr Jpn... 

Higuchi, N., Maruyama, H., Kuroda, T., Kameda, S., lino, N., Kawachi, H., Nishikawa, Y., Hanawa, H., Tahara, H., Miyazaki, J. and Gejyo, F. (2003). Hydrodynamics-based delivery of the viral interleukin-10 gene suppresses experimental crescentic glomerulonephritis in Wistar-Kyoto rats. Gene Ther. 10, 1297-1310. 

Koizumi R, Kanai H, Maezawa A, Kanda T, Nojima Y, Naruse T. Therapeutic effects of ulinastatin on experimental crescentic glomerulonephritis in rats. Nephron 2000 ... 

The protocol for inducing crescentic glomerulonephritis in mice was adapted from an earlier study (7), modified for our NTS to avoid rapid lethality from acute renal failure while ensuring adequate tissue injury for analysis (see Fig. 1). 

Kawasaki et al. (1992) induced crescentic glomerulonephritis with a small dose of nephrotoxic serum in WKY rats, which was characterized by the early infiltration of CD8 positive cells in glomeruli. In vivo depletion of CD8 positive cells completely prevented proteinuria and crescent formation. 

Kushiro M, Shikata K, Sugimoto H et al. (1998) Therapeutic effects of prostacyclin analog on crescentic glomerulonephritis of rat. Kidney Intern 53 1314-1320 Masugi M, Sato T (1934) Virchows Arch Pathol Anat Physiol Klin Med 293 615... 

In a 69-year-old man with penicillamine-induced crescentic glomerulonephritis ANCA tests were repeatedly negative (353). He had been taking penicillamine up to 750 mg/day for systemic sclerosis. 

Karpinski J, Jothy S, Radoux V, Levy M, Baran D. D-penicillamine-induced crescentic glomerulonephritis and antimyeloperoxidase antibodies in a patient with scleroderma. Case report and review of the literature. Am J Nephrol 1997 17(6) 528-32. 

Ogata H, Kubo M, Tamaki K, Hirakata H, Okuda S, Fujishima M. Crescentic glomerulonephritis due to rifampin treatment in a patient with pulmonary atypical myco-bacteriosis. Nephron I998 78(3) 319-22. 

Long-term outcomes in a series of seven children who developed myeloperoxidase-specific ANCA-positive necrotizing crescentic glomerulonephritis associated with propylthiouracil were studied in Japan (67). Three had nephritis alone and four had extrarenal vasculitis. All had taken glucocorticoids, some with additional drugs, and aU... 

Tipping PG, Timoshanko J Contributions of intrinsic renal cells to crescentic glomerulonephritis. Nephron Exp Nephrol 2005 101 el 73-8. 

Glomerulonephritis may be associated with chronic inflammatory bowel disease and has a heterogeneous expression [113]. Minimal change glomerulonephritis, membranous, membranoprohferative, focal glomerulosclerosis, and proliferative crescentic glomerulonephritis have been described and a summary of these case reports is available in the paper of Wilcox et al. [114]. In almost half of these cases, there was no relationship with drug intake such as sulphasalazine or 5-ASA. 

Devogelaer J-P, Pirson Y, Vandenbroucke J-M, Cosyns J-P, Brichard S, Deuxchaisnes CN. D-penicillamine induced crescentic glomerulonephritis Report and review of the literature. J Rheumatol 1987 14 1036-1041. 

OR = Odds ratio ANOA = anti-neutrophil q/toplasmic antibody G = Confidence interval SW = small vessel vasculitis GN = glomerulonephritis ""18 paucHmmune crescentic glomerulonephritis. 9 microscopic polyangitis. 4 Wegener s granulomatosis (Adapted with permission from De Broe et al. [117])... 

Salant DJ. Immunopathogenesis of crescentic glomerulonephritis and lung purpura. Kidney Int 1987 32 408-425. 

Gregorini G, Tira P, Lancini L, Bozzola G, Maiorca R. Silica exposure as a risk factor in the development of necrotising and crescentic glomerulonephritis with anti-mieloperoxidase antibodies. Nephrol Dial Transplant 1991 6 773 (abstract). 

Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. 

---